{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-24-003008","form_type":"8-K","ticker":"MCAG","cik":"0001859035","company_name":"Mountain Crest Acquisition Corp. V","filed_at":"2024-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.937372+00:00","generated_at":"2026-06-03T00:54:19.955506+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Mountain Crest V announces non-binding term sheet to combine with CUBEBIO at $620M pre-money value","bullets":["Pre-transaction equity value of CUBEBIO set at $620 million, subject to adjustment.","CUBEBIO is a Korea-based cancer diagnostics company using urine-based technology.","Non-binding term sheet dated April 26, 2024; definitive merger agreement yet to be signed.","Mountain Crest V is a SPAC; has completed four prior business combinations.","Global Fund LLC engaged as advisor to CUBEBIO."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-24-003008","json":"https://secwatch.observer/filing/0001829126-24-003008.json","markdown":"https://secwatch.observer/filing/0001829126-24-003008.md","text":"https://secwatch.observer/filing/0001829126-24-003008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859035/000182912624003008/0001829126-24-003008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859035/000182912624003008/mountaincre5_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T00:54:19.955506+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}